Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,073 shares at $448.00 ($3.2M) on 2024-05-22, disclosed to the SEC on 2024-05-24.
Scheduled sale ($3.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-07-18 | $8.0M | — | Filing → |
| VRTX | SELL | 2023-04-14 | $13.9M | — | Filing → |